Risk Factors for Late-Stage HIV Disease Presentation at Initial HIV Diagnosis in Durban, South Africa

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Drain, Paul K ^a,b   Losina, Elena ^a,b,e   Parker, Gary ^g   Giddy, Janet ^g   Ross, Douglas ^h   Katz, Jeffrey N ^b,d   Coleman, Sharon M ^e   Bogart, Laura M ^c,f   Freedberg, Kenneth A ^a,c,d,e   Walensky, Rochelle P ^a,b,c   Bassett, Ingrid V ^a,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^f BOSTON CHILDREN S HOSPITAL   (United States)

^g MCCORD HOSPITAL   (South Africa)

^h St Mary's Hospital   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN;

ADULT; ANTIGEN DETECTION; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; EMOTIONAL STABILITY; FEMALE; HEALTH CARE ACCESS; HEALTH CARE NEED; HEALTH CARE UTILIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; RISK ASSESSMENT; SOCIAL SUPPORT; SOUTH AFRICA; SURVIVAL RATE; SYNDROME DELINEATION;

CD4-POSITIVE T-LYMPHOCYTES; CELL COUNT; DISEASE PROGRESSION; GEOGRAPHY; HIV INFECTIONS; HUMANS; ODDS RATIO; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RISK FACTORS; SOCIOECONOMIC FACTORS; SOUTH AFRICA;

EID: 84873801413     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0055305     Document Type: Article

References (49)

1. Joint United Nations Programme on HIV/AIDS (2011) UNAIDS Global Report 2010. Geneva: UNAIDS. 229 p.
2. Joint United Nations Programme on HIV/AIDS (2011) UNAIDS Data Tables 2011. Geneva: UNAIDS. 12 p.
3. South Africa Department of Health (2011) Comprehensive Care, Management, and Treatment of HIV and AIDS. Pretoria: National Data.
4. May M, Boulle A, Phiri S, Messou E, Myer L, et al. (2010) Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: A collaborative analysis of scale-up programmes. Lancet 376: 449-457.
5. Castilla J, Sobrino PB, de la Fuente LAB, Noguer I, Guerra L, et al. (2002) Late diagnosis of HIV infection in the era of highly active antiretroviral therapy: Consequences for AIDS incidence. AIDS 16: 1945-1951.
6. Egger M, May M, Chene G, Phillips AN, Ledergerber B, et al. (2002) Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: A collaborative analysis of prospective studies. Lancet 360: 119-129.
7. Krentz HB, Auld MC, Gill MJ, (2004) The high cost of medical care for patients who present late (CD4<200 cells/uL) with HIV infection. HIV Medicine 5: 93-98.
8. Sabin CA, Smith CJ, Gumley H, Murphy G, Lampe FC, et al. (2004) Late presenters in the era of highly active antiretroviral therapy: Uptake of and responses to antiretroviral therapy. AIDS 18: 2145-2151.
9. Badri M, Lawn SD, Wood R, (2006) Short-term risk of AIDS or death in people infected with HIV-1 before antiretroviral therapy in South Africa: A longitudinal study. Lancet 368: 1254-1259.
10. Toure S, Kouadio B, Seyler C, Traore M, Dakoury-Dogbo N, et al. (2008) Rapid scaling-up of antiretroviral therapy in 10,000 adults in Cote d'Ivoire: 2-year outcomes and determinants. AIDS 22: 873-882.
11. Mills EJ, Bakanda C, Birungi J, Chan K, Ford N, et al. (2011) Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda. Ann Intern Med 155: 209-216.
12. Mascolini M (2011) South Africa raises threshold for starting ART to 350 CD4 cells. International AIDS Society, August 17, 2011. Available: http://www.iasociety.org/Default.aspx?pageId=5&elementId=13825. Accessed 13 May 2012.
13. Lawn SD, Harries AD, Anglaret X, Myer L, Wood R, (2008) Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS 22: 1897-1908.
14. Ford N, Kranzer K, Hilderbrand K, Jouquet G, Goemaere E, et al. (2010) Early initiation of antiretroviral therapy and associated reduction in mortality, morbidity and defaulting in a nurse-managed, community cohort in Lesotho. AIDS 24: 2645-2650.
15. Chesney MA, Smith AW, (1999) Critical delays in HIV testing and care: the potential role of stigma. Am Behav Scientist 42: 1162-1174.
16. Samet JH, Freedberg KA, Stein MD, Lewis R, Savetsky J, et al. (1998) Trillion virion delay: Time from testing positive for HIV to presentation for primary care. Arch Intern Med 58: 734-740.
17. Craw JA, Gardner LI, Marks G, Rapp RC, Bosshart J, et al. (2008) Brief strengths-based case management promotes entry into HIV medical care: results of the antiretroviral treatment access study-II. J Acquir Immune Defic Syndr 47: 597-606.
18. Hays RD, Sherbourne CD, Mazel RM, (1993) The RAND 36-Item Health Survey 1.0. Health Econ. 2: 217-227.
19. Sherbourne CD, Stewart AL, (1991) The MOS social support survey. Soc Sci Med 32: 705-714.
20. Cunningham WE, Andersen RM, Katz MH, Stein MD, Turner BJ, et al. (1999) The impact of competing subsistence needs and barriers on access to medical care for persons with Human Immunodeficiency Virus receiving care in the United States. Med Care 37: 1270-1281.
21. Kigozi IM, Dobkin LM, Martin JN, Geng EH, Muyindike W, et al. (2009) Late disease stage at presentation to an HIV clinic in the era of free antiretroviral therapy in sub-Saharan Africa. J Acquir Immune Defic Syndr 52: 280-289.
22. Wanyenze RK, Kamya MR, Fatch R, Mayanja-Kizza H, Baveewo S, et al. (2011) Missed opportunities for HIV testing and late-stage diagnosis among HIV-infected patients in Uganda. PLoS One 6: e21794.
23. Abaynew Y, Deribew A, Deribe K, (2011) Factors associated with late presentation to HIV/AIDS care in South Wollo Zone Ethiopia: a case-control study. AIDS Res Ther 8: 8.
24. Zachariah R, Harries AD, Manzi M, Gomani P, Teck R, et al. (2006) Acceptance of anti-retroviral therapy among patients infected with HIV and Tuberculosis in rural Malawi is low and associated with cost of transport. PLoS One 1: e121.
25. Posse M, Baltussen R, (2009) Barriers to access to antiretroviral treatment in Mozambique, as perceived by patients and health workers in urban and rural settings. AIDS Patient Care and STDs 23: 867-875.
26. Losina E, Bassett IV, Giddy J, Chetty S, Regan S, et al. (2010) The "ART' of linkage: pre-treatment loss to care after HIV diagnosis at two PEPFAR sites in Durban, South Africa. PLoS One. 5: e9538.
27. Fox MP, Mazimba A, Seidenberg P, Crooks D, Sikateyo B, et al. (2010) Barriers to initiation of antiretroviral treatment in rural and urban areas of Zambia: a cross-sectional stud of cost, stigma, and perceptions about ART. J Int AIDS Soc 13: 1-11.
28. Miller CM, Ketlhapile M, Rybassack-Smith H, Rosen S, (2010) Why are antiretroviral treatment patients lost to follow-up? A qualitative study from South Africa. Trop Med Int Health 15: 48-54.
29. Mills EJ, Ford N, (2012) Home-based HIV counseling and testing as a gateway to earlier initiation of antiretroviral therapy. Clin Infect Dis 54: 282-284.
30. Wachira J, Kimaiyo S, Ndege S, Mamlin J, Braitstein P, (2012) What is the impact of home-based HIV counseling and testing (HBCT) on the clinical status of newly enrolled adults in a large HIV care program in western Kenya? Clin Infect Dis 54: 275-281.
31. Tumwesigye E, Wana G, Kasasa S, Muganzi E, Nuwaha F, (2010) High uptake of home-based, district-wide, HIV counseling and testing in Uganda. AIDS Patient Care STDs 24: 735-741.
32. Muula AS, Ngulube TJ, Siziya S, Makupe CM, Umar E, et al. (2007) Gender distribution of adult patients on highly active antiretroviral therapy (HAART) in southern Africa: a systematic review. BMC Public Health 7: 63.
33. Weiser SD, Heisler M, Leiter K, Percy-de Korte F, Tlou S, et al. (2006) Routine HIV testing in Botswana: a population-based study on attitudes, practices, and human rights concerns. PLoS Med 3: e261.
34. Nagata JM, Magerenge RO, Young SL, Oguta JO, Weiser SD, et al. (2012) Social determinants, lived experiences, and consequences of household food insecurity among persons living with HIV/AIDS on the shore of Lake Victoria, Kenya. AIDS Care 24: 728-736.
35. Weiser SD, Tuller D, Frongillo E, Senkungu J, Mukiibi N, et al. (2010) Food insecurity as a barrier to sustained antiretroviral therapy adherence in Uganda. PLoS One 5: e10340.
36. Weiser SD, Tsai AC, Gupta R, Frongillo EA, Kawuma A, et al. (2012) Food insecurity is associated with morbidity and patterns of healthcare utilization among HIV-infected individuals in a resource-poor setting. AIDS 26: 67-75.
37. Ivers L, Cullen K, Freedberg K, Block S, Coates J, et al. (2009) HIV/AIDS, undernutrition, and food insecurity. Clin Infect Dis 49: 1092-1102.
38. Ciesla JA, Roberts JE, (2001) Meta-analysis of the relationship between HIV infection and risk for depressive disorders. Am J Psychiatry 158: 725-730.
39. Justice AC, McGinnis KA, Atkinson JH, Heaton RK, Young C, et al. (2004) Psychiatric and neurocognitive disorders among HIV-positive and negative veterans in care: veterans aging cohort five-site study. AIDS (Suppl 1): S49-59.
40. Prince M, Patel V, Saxena S, Maj M, Maselko J, et al. (2007) No health without mental health. Lancet 370: 859-877.
41. Ramirez-Avila L, Regan S, Giddy J, Chetty S, Ross D, Katz JN, et al. (2012) Depressive symptoms and their impact on health-seeking behaviors in newly-diagnosed HIV-infected patients in Durban, South Africa. AIDS Behav. Epub ahead of print.
42. Maj M, Janssen R, Starace F, Zaudig M, Satz P, et al. (1994) WHO neuropsychiatric AIDS study, cross-sectional phase I. Study design and psychiatric findings. Arch Gen Psychiatry 51: 39-49.
43. Ickovics JR, Hamburger ME, Vlahov D, Schoenbaum EE, Schuman P, et al. (2001) Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study. JAMA 285: 1466-1474.
44. Byakika-Tusiime J, Oyugi JH, Tumwikirize WA, Katabira ET, Mugyenyi PN, et al. (2005) Adherence to HIV antiretroviral therapy in HIV+ Ugandan patients purchasing therapy. Int J STD AIDS 16: 38-41.
45. Tadios Y, Davey G, (2006) Antiretroviral treatment adherence and its correlates in Addis Ababa, Ethiopia. Ethiop Med J 44: 237-244.
46. National Department of Health, Republic of South Africa (2010) National HIV Counseling and Testing (HCT) Policy Guidelines. Pretoria: National Department of Health.
47. Park BJ, Wannemuehler KA, Marston BJ, Govender N, Pappas PG, et al. (2009) Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 23: 525-530.
48. Bassett IV, Regan S, Chetty S, Giddy J, Uhler LM, et al. (2010) Who starts antiretroviral therapy in Durban, South Africa? not everyone who should. AIDS (Suppl 1): S37-44.
49. Rosen S, Fox MP, (2011) Retention in HIV care between testing and treatment in sub-Saharan Africa: a systematic review. PLoS Med 8: e1001056.